The United States Food and Drug Administration (FDA) has suspended the licence of one of the two chikungunya vaccines available in the country, following chikungunya-like illness in recipients of the shot.

U.S. health authorities have suspended the license for the Ixchiq vaccine against the chikungunya virus following reports of "serious adverse events", the drug's French maker said on Monday.

The United States Food and Drug Administration (FDA) has suspended the license for Valneva's chikungunya vaccine Ixchiq with immediate effect, the French drugmaker said on Monday. Valneva said the suspension follows four reports of serious adverse events consistent with the disease,